ArticleScientific reports2025
Salivary hormonal analysis as a tool for skeletal maturity assessment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current evidence suggests a strong correlation between specific body hormones and skeletal maturation; however, there is very limited literature available on salivary hormonal levels and their correlation with craniofacial skeletal growth. The primary objective of this study was to collect preliminary data on the salivary Growth Hormone, Cortisol, Testosterone, and 17β-Estradiol levels of orthodontic patients with specific age groups. In this cross-sectional cohort study, a total of 80 patients (40 females and 40 males) were recruited. 5 ml saliva was collected by a passive drooling method for an ELISA test of Cortisol, 17β-Estradiol, Testosterone, and Growth Hormone (GH). Lateral cephalograms were acquired for the middle phalanx of the third figure (MP3) stages and Cervical Vertebral Maturity Indicator (CVMI). We observed that the GH concentration was highest for females between the ages of 10-11 years (12.0 ± 4.2 pg/ml) and for males between the ages of 13-14 years (13.4 ± 11.6 pg/ml). The prepubertal stage (10-12 years) for female subjects, MP3, and CVMI stages were observed to be 2.5. This study concludes that the salivary growth hormone was highest for ages 10-11 females and age 13-14 males, then gradually declined as the age of the subjects increased. The trend for the Testosterone level was identical between males and females till the age of 13; thereafter, males showed higher salivary Testosterone than female subjects. These findings show promising application of salivary hormonal analysis for the growth prediction. Specifically, level of salivary GH can be used as a non-invasive tool for the skeletal maturation assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.